CClinicalTrials.gg
RecruitingNCT05943730Updated Mar 6, 2024

Validity of Measuring Preoperative Fitness Using Seismofit

An interventional study of Seismofit in Preoperative Care and Validity, sponsored by Northumbria University. Recruiting at 3 sites in United Kingdom. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by Northumbria University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Aug 2023; still recruiting 3 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
143
Allocation
Not applicable
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Physical fitness levels of people waiting for a planned operation are often measured using an exercise test. This is because fitness levels help doctors make a plan to improve each person's chances of a successful recovery after their planned operation. The exercise test requires skilled staff, expensive equipment, a 1 hour appointment, and the patient to exercise heavily during the test.

Ventriject, a small to medium sized enterprise, have designed a device called Seismofit that estimates fitness levels of people from a measurement taken whilst laying down. It measures the vibrations of the chest wall caused by the beating heart and uses this information with additional information, such as height, weight and sex, to estimate fitness. The measurement takes around 5 minutes to perform, does not require heavy exercise, expensive equipment or skilled staff.

The Seismofit device was shown to be accurate in young fairly fit people. It has not been tested in people who undergo an exercise test before an operation, who are less fit on average compared to the people that the device was originally tested on. It is likely that the calculations used to estimate fitness levels with the Seismofit device will need to be adjusted for people waiting for an operation. There are two parts to this study. The first part aims to estimate up to 50 people's fitness with the Seismofit device and use directly measured fitness from their standard exercise test before their operation to adjust the calculations for estimating fitness. The second part of this study aims to have a further 50 people undergo the Seismofit device measurement and compare the estimated fitness level with the results from the standard exercise test before an operation. This is to see if the Seismofit device is valid at estimating fitness in people awaiting surgery.

02

Conditions studied

  • Preoperative Care
  • Validity

Keywords

  • Seismocardiography
  • Preoperative Exercise
  • Peak oxygen uptake
  • VO2max
  • Cardiopulmonary exercise test
03

In context

Lead sponsor

Northumbria University is the lead sponsor of 156 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults awaiting major or complex elective surgery classified by the NICE NG45 guideline
  • Referred for and capable of performing a maximum effort CPET as part of standard care within their preoperative assessment
  • Able to be fully supine for 5 minutes

Exclusion criteria

Exclusion:

  • Pacemaker, implantable defibrillator, or any other implantable electronic device in situ
  • Permanent Atrial fibrillation, or other persistent arrhythmia (such as, atrial flutter, bigeminy, trigeminy, frequent premature atrial/ventricular complexes, 2nd degree heart block) documented in the patient's medical history
  • Body mass index (BMI) >35 kg.m-2
  • Severe COPD (defined as FEV1 % predicted \<50% [GOLD report, 2022])
  • Pectus excavatum or other chest wall deformity
  • Claudication that limits exercise tolerance
  • Unable to perform maximal CPET
  • Refusal to give informed consent
  • Presence of an absolute contraindication to CPET detailed in the POETTS clinical guideline (Levett et al. 2018).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
143 participants (estimated)

Study arms

  • Experimental
    Seismofit Validity

    Participants will undergo a seismocardiography assessment, whilst supine, using the seismofit device. This will estimate their peak oxygen consumption. Participants will then undergo a maximal cardiopulmonary exercise test (CPET), where peak oxygen consumption will be measured. The Seismofit estimated peak oxygen consumption will be compared with CPET measured peak oxygen consumption (unless prespecified criteria for a maximal exercise test are not met).

    Device: Seismofit

Interventions

  • DeviceSeismofit

    The Seismofit device uses seismocardiography to estimate peak oxygen consumption from a resting measurement. This study will assess its validity against the gold standard measure of peak oxygen consumption, cardiopulmonary exercise test, conducted as part of standard care.

06

What researchers measure

Primary outcomes

  1. Phase 1 outcome - refine algorithm

    Up to 50 patients awaiting major surgery will have their estimated V̇O2peak (ml/kg/min) recorded using the Seismofit device and actual V̇O2peak (ml/kg/min) measured in their standard preoperative cardiopulmonary exercise test. The Seismofit algorithm will be adjusted using these data points with machine learning.

    Time frame: Up to 6 months

  2. Phase 2 outcome - validity of refined algorithm

    The correlation between the new seismofit algorithm estimate of V̇O2peak (ml/kg/min) and CPET measured and verified V̇O2peak (ml/kg/min) in up to 50 preoperative patients that have valid tests in accordance with maximal exercise test criteria stated in the protocol (RER \> 1.10 or maximum heart rate attained within 10 beats of predicted maximum).

    Time frame: 12 months

Secondary outcomes

  1. Bland-Altman analysis

    Agreement between Seismofit estimated V̇O2peak (ml/kg/min) and CPET measured V̇O2peak (ml/kg/min) using Bland-Altman analysis.

    Time frame: 12 months

  2. Existing V̇O2peak predicted equation analysis

    To calculate the correlation and agreement between existing equations used to predict V̇O2peak (ml/kg/min) with directly measured V̇O2peak (ml/kg/min) to observe how these data compare with the Seismofit correlation and agreement data.

    Time frame: 12 months

Other outcomes

  1. Seismofit total population analysis

    Correlation between Seismofit estimated V̇O2peak (ml/kg/min) and CPET measured V̇O2peak (ml/kg/min), including patients that did not meet maximum effort criteria for CPET (RER \>1.10 or \<10 beats/min estimated maximum heart rate).

    Time frame: 12 months

07

Study locations

3 of 3 sites recruiting
  • South Tees Hospitals NHS Foundation Trust
    Middlesbrough, United Kingdom
    Recruiting
  • Sheffield Teaching Hospitals NHS Foundation Trust
    Sheffield, United Kingdom
    Recruiting
  • York and Scarborough NHS Foundation Trust
    York, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05943730
Lead sponsor
Northumbria University
Collaborators
South Tees Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, York Teaching Hospitals NHS Foundation Trust, Ventriject, Denmark, Aalborg University
Responsible party
Sponsor
First posted
Jul 13, 2023
Start date
Aug 31, 2023
Primary completion
Aug 1, 2024 (estimated)
Completion
Aug 1, 2024 (estimated)
Last update
Mar 6, 2024

Study contacts

Alasdair O'Doherty, PhD
Contact
alasdair.odoherty@northumbria.ac.uk
01913495377

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion